Publications

Export 15 results:
Sort by: Author [ Title (Asc)] Type Year
Filters: Author is Nyirenda, Moffat J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
5
McCormick JA, Lyons V, Jacobson MD, Noble J, Diorio J, Nyirenda M, et al. 5’-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcripts by early-life events. Molecular endocrinology (Baltimore, Md.). 2000;14:506-17. Abstract
G
Seckl JR, Nyirenda MJ, Walker BR, Chapman KE. Glucocorticoids and fetal programming. Biochem Soc Trans. 1999;27(2):74-8.
H
Nyirenda MJ, Tang JI, Padfield PL, Seckl JR. Hyperkalaemia. BMJ. 2009;339:b4114.
I
Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. J Endocrinol. 1999;160(1):103-9. Abstract
Nyirenda MJ, Seckl JR. Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure (Review). International journal of molecular medicine. 1998;2:607-14. Abstract
Cleasby ME, Livingstone DE, Nyirenda MJ, Seckl JR, Walker BR. Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood? European journal of endocrinology / European Federation of Endocrine Societies. 2003;148:129-38. Abstract
M
Macfarlane DP, Zou X, Andrew R, Morton NM, Livingstone DE, Aucott RL, et al. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis. Am J Physiol Endocrinol Metab. 2011;300(2):E402-9. Abstract
Macfarlane DP, Zou X, Andrew R, Morton NM, Livingstone DE, Aucott RL, et al. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency; implications for the pathogenesis of steatohepatitis. Am J Physiol Endocrinol Metab. 2010. Abstract
P
Nyirenda MJ, Padfield PL. Parathyroid hormone and hypertension. Journal of hypertension. 2005;23:1633-4.
Tang JI, Kenyon CJ, Seckl JR, Nyirenda MJ. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat. J Hypertens. 2011;29(2):282-9. Abstract
Nyirenda MJ, Dean S, Lyons V, Chapman KE, Seckl JR. Prenatal programming of hepatocyte nuclear factor 4alpha in the rat: A key mechanism in the ’foetal origins of hyperglycaemia’? Diabetologia. 2006;49:1412-20. Abstract
Nyirenda MJ, Carter R, Tang JI, de Vries A, Schlumbohm C, Hillier SG, et al. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes. 2009;58(12):2873-9. Abstract
Nyirenda MJ, Welberg LA, Seckl JR. Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids-fetal effect or maternal influence? The Journal of endocrinology. 2001;170:653-60. Abstract
T
Nyirenda MJ, Clark DN, Finlayson AR, Read J, Elders A, Bain M, et al. Thyroid disease and increased cardiovascular risk. Thyroid : official journal of the American Thyroid Association. 2005;15:718-24. Abstract
Nyirenda MJ, Taylor PN, Stoddart M, Beckett GJ, Toft AD. Thyroid-stimulating hormone-receptor antibody and thyroid hormone concentrations in smokers vs nonsmokers with Graves disease treated with carbimazole. JAMA. 2009;301(2):162-4.